8-KEarnings & ResultsExhibits & Filings

IDEXX LABORATORIES INC /DE 8-K Report, Financial Results (Oct 24, 2014)

Filed October 24, 2014For Securities:IDXX

Summary

IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on October 24, 2014, to announce its financial results for the third quarter ended September 30, 2014. The primary purpose of this filing is to furnish investors with the company's earnings press release, which details its performance during the period. While the 8-K itself is a standard reporting document, the accompanying press release (Exhibit 99.1) is the crucial investor-facing document. Investors would refer to this press release for key financial metrics, operational highlights, and potentially forward-looking statements that provide insight into the company's trajectory. The filing emphasizes that this information is furnished under Item 2.02 and is not deemed 'filed' for the purposes of Section 18 of the Exchange Act, a common disclaimer for earnings announcements.

Key Highlights

  • 1IDEXX Laboratories announced its financial results for the third quarter of 2014.
  • 2The announcement was made via a press release furnished as part of the 8-K filing.
  • 3The event date for the earliest reported event was October 23, 2014, with the filing date of October 24, 2014.
  • 4The filing pertains to Item 2.02 (Results of Operations and Financial Condition).
  • 5Exhibit 99.1 contains the full text of the earnings press release.
  • 6Information furnished under Item 2.02 is typically not considered 'filed' for certain legal liabilities.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and provide investors with IDEXX Laboratories' financial results for the third quarter ended September 30, 2014, through an accompanying press release.

The detailed financial results are contained within the press release titled 'IDEXX Laboratories Announces Third Quarter Results,' which is furnished as Exhibit 99.1 to this 8-K report.

This disclaimer means that while the information is publicly disclosed, it is not subject to the same liability under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed.' This is a standard practice for earnings releases furnished under Item 2.02.

The 8-K report was signed by Brian P. McKeon, Executive Vice President, Chief Financial Officer, and Treasurer of IDEXX Laboratories, Inc.